Article By:
ChinaBio® Today
Saturday, June 3, 2017 1:44 PM EDT
Cirina, a Hong Kong cancer diagnostics company, will merge with GRAIL, a Menlo Park startup, which is also developing non-invasive early-stage molecular cancer diagnostics.
In this article: LLY, ILMN, THLD, HCM, ACIU